雪榕生物: 国浩律师（上海）事务所关于上海雪榕生物科技股份有限公司2025年第二次临时股东大会的法律意见书

Group 1 - The company held its second extraordinary general meeting of shareholders in 2025 on August 4, 2025, at a specified location in Shanghai, combining both in-person and online participation [3][4] - The meeting was convened following a proposal from the company's board of directors on July 17, 2025, and the notice was published on July 18, 2025, in accordance with legal requirements [2][3] - A total of 3 shareholders attended the meeting, representing 126,370,700 shares, which accounts for 21.1448% of the company's total shares [4] Group 2 - The voting process included both on-site and online voting, with specific time slots allocated for online participation on the same day [3][5] - The meeting's agenda was approved through a voting process that adhered to the company's articles of association, ensuring the protection of minority investors by counting votes separately for them [5] - The legal opinion concluded that all procedures for convening and conducting the meeting, as well as the qualifications of attendees and the voting process, were in compliance with relevant laws and regulations [5]